FDA’s decision to authorize state-licensed pharmacists to prescribe Paxlovid, within the limitations of and for those indications stated in the emergency use authorization, has the potential to expand access to timely treatment.
FDA’s decision to authorize state-licensed pharmacists to prescribe Paxlovid, within the limitations of and for those indications stated in the emergency use authorization, has the potential to expand access to timely treatment.
IDSA is pleased to see increased funding to strengthen the federal response to antimicrobial resistance, bolster the domestic and global fight against COVID-19, combat the infectious diseases impacts of the opioid crisis and strengthen global security in two recently passed appropriations bills.
As the term of Robert T. Schooley, MD, FIDSA, as editor-in-chief of Clinical Infectious Diseases ends, the Infectious Diseases Society of America wishes to thank him and all members of his editorial board for their extraordinary work as journal and Society leaders.
Increasing access to monkeypox testing and expanding vaccination against infection to people at high risk are needed and welcome steps in efforts to control spread and minimize symptoms.
Antimicrobial resistance — what infectious diseases experts warn could become the next pandemic — is poised to receive much needed federal investment.
IDSA and HIVMA condemn the U.S. Supreme Court decision overturning Roe v. Wade that sanctions government interference in patient autonomy and care and threatens the sanctity of the provider-patient relationship.
People who may be most in need of antiviral treatment for COVID-19 may not be receiving it because of where they live, according to a recent report from the U.S. Centers for Disease Control and Prevention.
IDSA supports the decision by the Food and Drug Administration and the Centers for Disease Control and Prevention to authorize the Pfizer-BioNTech and Moderna COVID-19 vaccines for young children and infants ages 5 years and younger.
IDSA in collaboration with CDC has selected 11 ID programs for the first Joint ID/CDC Epidemic Intelligence Service Fellowship. Each of the 11 programs will serve as options for the ID fellowship track for the joint IDSA and CDC training program.
IDSA and HIVMA echo the concern expressed by UNAIDS about the use of racist and homophobic language regarding the current monkeypox outbreak.
IDSA supports decisions by the Food and Drug Administration and the Centers for Disease Control and Prevention to recommend COVID-19 vaccine booster shots for children ages 5-11 who have already completed the two-shot primary series.
What was once unfathomable – one million people dying from COVID-19 -- is a reality that is difficult to comprehend. Infectious diseases experts throughout the nation mourn the immense loss of life.